Skip to Content

Wednesday, January 24th, 2018

Provinces agreed on coordinative efforts against violators of Drug Licensing Registration and Quality


Islamabad, December 13, 2016 (PPI-OT):DRAP at Federal level and provinces shared their activities, issues and way forward. Similarly some pending amendments in legislation were also reviewed and provinces will respond to DRAP, after taking up with their respective departments.

Various actions against illegal and unauthorized manufacturing and their sales by the federal inspectors and by provinces especially Punjab government were presented, for both allopathic and alt. med and nutraceuticals. For nutraceuticals DRAP informed about the approved and rejected cases for nutraceuticals companies enlistment have been uploaded on its website, so provinces can review these and can take actions against violators.

KPK also shared their experience and informed about the recent action taken and notification issued by their govt. Baluchistan presented about the illegal import of spurious drugs from neighbouring country and local packaging of these as health products or alternate medicines by spurious drug makers. Baluchistan further express interest and requested Punjab and KPK for working paper for their procurement procedure that they applied, that is ‘Quality and Price tendering’ method, instead of ‘price only’ which in the past was allowing more chances for corruption and patients suffered due to poor quality drugs.

It was further requested for the procedure that was adopted for Pre-qualification of companies before price tender. Similarly KPK also shared their recent ‘quality and price’ public procurement method. New initiatives by DRAP like 2D bar code regulations were discussed and its benefit for patient care and safety, in addition to efficiency and cost effectiveness were deliberated. Furthermore participants were briefed about the proposed amendments in schedule II and III of the drug act.

It was emphasized that the capacity building efforts are of paramount importance for both regulators and pharmaceutical industry. DRAP is now continuously providing this support to regulatory staff of federal, field offices and provincial staff, and to industry, through its indigenous and WHO and USP experts.

For ensuring quality if drugs, international accreditation of public drug testing labs is necessary. DRAP is proceeding for its Central drug testing lab at Karachi for WHO pre-qualification. Punjab is also proceeding for one of its drug testing lab. Other provinces were requested to take up with their governments for upgrading their drug testing labs too. This will not only ensure the quality control for domestic drug supplies but will also built confidence for quality drugs export.

An inter provincial coordination meeting convened in Islamabad by Drug Regulatory Authority of Pakistan. It was agreed to have coordinated efforts against the violators of drug registration, licensing, quality and pricing, and other rules and against the menace of spurious, substandard, fake and falsified drugs makers and traders, in the larger interest of the patient and country.

Supporting access of assured quality and safe drugs for patients is our joint responsibility. With such joint and coordinated efforts the people in whole of Pakistan will benefit. It was agreed to hold meeting after every two months, so as to take all on board and coordinated through updates amongst DRAP and provincial governments on all issues and future plans.

For more information, contact:
Principal Information Officer
Press Information Department (PID)
Tel: +92-51-9252323 and +92-51-9252324
Fax: +92-51-9252325 and +92-51-9252326